Comprehensive metagenomic analysis of glioblastoma reveals absence of known virus despite antiviral-like type i interferon gene response

International Journal of Cancer

Volumn 135, Issue 6, 2014, Pages 1381-1389

  Cosset, Érika ^a   Petty, Tom J ^b,c   Dutoit, Valérie ^a   Cordey, Samuel ^d   Padioleau, Ismael ^b,c   Otten Hernandez, Patricia ^e   Farinelli, Laurent ^e   Kaiser, Laurent ^d   Bruyère Cerdan, Pascale ^a   Tirefort, Diderik ^a   Amar El Dusouqui, Soraya ^a   Nayernia, Zeynab ^a   Krause, Karl Heinz ^a   Zdobnov, Evgeny M ^b,c   Dietrich, Pierre Yves ^a   Rigal, Emmanuel ^a   Preynat Seauve, Olivier ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^c SWISS INSTITUTE OF BIOINFORMATICS   (Switzerland)

^d GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^e FASTERIS SA   (Switzerland)

Author keywords

antiviral type I interferon response; glioblastoma multiforme; high throughput sequencing; metagenomic analysis; virus discovery

Indexed keywords

INTERFERON;

ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; GENOME ANALYSIS; GLIOBLASTOMA; HIGH THROUGHPUT SEQUENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MATHEMATICAL COMPUTING; METAGENOMICS; NONHUMAN; PRIORITY JOURNAL; RNA SEQUENCE; SCREENING TEST; SENDAI VIRUS INFECTION; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; TUMOR BIOPSY; TYPE I INTERFERON GENE; VALIDATION PROCESS; VIRUS DETECTION; VIRUS IDENTIFICATION;

ANTIVIRAL TYPE I INTERFERON RESPONSE; GLIOBLASTOMA MULTIFORME; HIGH-THROUGHPUT SEQUENCING; METAGENOMIC ANALYSIS; VIRUS DISCOVERY;

ANTIBODIES, VIRAL; BRAIN NEOPLASMS; CYTOMEGALOVIRUS; GLIOBLASTOMA; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERFERON TYPE I; METAGENOMICS;

EID: 84904012166     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28670     Document Type: Article

References (34)

1. Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007; 114: 97-109.
2. Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005; 352: 987-996.
3. Schwartzbaum JA, Fisher JL, Aldape KD, et al. Epidemiology and molecular pathology of glioma. Nat Clin Pract Neurol 2006; 2: 494-503; quiz 1 p following 16.
4. Ohgaki H, Kleihues P,. Epidemiology and etiology of gliomas. Acta Neuropathol 2005; 109: 93-108.
5. Kouhata T, Fukuyama K, Hagihara N, et al. Detection of simian virus 40 DNA sequence in human primary glioblastomas multiforme. J Neurosurg 2001; 95: 96-101.
6. Zhen HN, Zhang X, Bu XY, et al. Expression of the simian virus 40 large tumor antigen (Tag) and formation of Tag-p53 and Tag-pRb complexes in human brain tumors. Cancer 1999; 86: 2124-2132.
7. Cobbs CS, Harkins L, Samanta M, et al. Human cytomegalovirus infection and expression in human malignant glioma. Cancer Res 2002; 62: 3347-3350.
8. Mitchell DA, Xie W, Schmittling R, et al. Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma. Neuro Oncol 2008; 10: 10-18.
9. Sabatier J, Uro-Coste E, Pommepuy I, et al. Detection of human cytomegalovirus genome and gene products in central nervous system tumours. Br J Cancer 2005; 92: 747-750.
10. Scheurer ME, Bondy ML, Aldape KD, et al. Detection of human cytomegalovirus in different histological types of gliomas. Acta Neuropathol 2008; 116: 79-86.
11. Lucas KG, Bao L, Bruggeman R, et al. The detection of CMV pp65 and IE1 in glioblastoma multiforme. J Neurooncol 2011; 103: 231-238.
12. Dziurzynski K, Chang SM, Heimberger AB, et al. Consensus on the role of human cytomegalovirus in glioblastoma. Neuro Oncol 2012; 14: 246-255.
13. Soderberg-Naucler C, Rahbar A, Stragliotto G,. Survival in patients with glioblastoma receiving valganciclovir. N Engl J Med 2013; 369: 985-986.
14. Lau SK, Chen YY, Chen WG, et al. Lack of association of cytomegalovirus with human brain tumors. Mod Pathol 2005; 18: 838-843.
15. Poltermann S, Schlehofer B, Steindorf K, et al. Lack of association of herpesviruses with brain tumors. J Neurovirol 2006; 12: 90-99.
16. Bzhalava D, Johansson H, Ekstrom J, et al. Unbiased approach for virus detection in skin lesions. PLoS One 2013; 8: e65953.
17. Khoury JD, Tannir NM, Williams MD, et al. Landscape of DNA virus associations across human malignant cancers: analysis of 3,775 cases using RNA-Seq. J Virol 2013; 87: 8916-8926.
18. Preynat-Seauve O, Suter DM, Tirefort D, et al. Development of human nervous tissue upon differentiation of embryonic stem cells in three-dimensional culture. Stem Cells 2009; 27: 509-520.
19. Li H, Durbin R,. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 2009; 25: 1754-1760.
20. Luo R, Liu B, Xie Y, et al. SOAPdenovo2: an empirically improved memory-efficient short-read de novo assembler. Gigascience 2012; 1: 18.
21. Sadler AJ, Williams BR,. Interferon-inducible antiviral effectors. Nat Rev Immunol 2008; 8: 559-568.
22. Duarte CW, Willey CD, Zhi D, et al. Expression signature of IFN/STAT1 signaling genes predicts poor survival outcome in glioblastoma multiforme in a subtype-specific manner. PLoS One 2012; 7: e29653.
23. Khodarev NN, Beckett M, Labay E, et al. STAT1 is overexpressed in tumors selected for radioresistance and confers protection from radiation in transduced sensitive cells. Proc Natl Acad Sci U S A 2004; 101: 1714-1719.
24. Tsai MH, Cook JA, Chandramouli GV, et al. Gene expression profiling of breast, prostate, and glioma cells following single versus fractionated doses of radiation. Cancer Res 2007; 67: 3845-3852.
25. Bhanoori M, Yellaturu CR, Ghosh SK, et al. Thiol alkylation inhibits the mitogenic effects of platelet-derived growth factor and renders it proapoptotic via activation of STATs and p53 and induction of expression of caspase1 and p21(waf1/cip1). Oncogene 2003; 22: 117-130.
26. Chin YE, Kitagawa M, Kuida K, et al. Activation of the STAT signaling pathway can cause expression of caspase 1 and apoptosis. Mol Cell Biol 1997; 17: 5328-5337.
27. Meister N, Shalaby T, von Bueren AO, et al. Interferon-gamma mediated up-regulation of caspase-8 sensitizes medulloblastoma cells to radio- and chemotherapy. Eur J Cancer 2007; 43: 1833-1841.
28. Sironi JJ, Ouchi T,. STAT1-induced apoptosis is mediated by caspases 2, 3, and 7. J Biol Chem 2004; 279: 4066-4074.
29. Chin YE, Kitagawa M, Su WC, et al. Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21 WAF1/CIP1 mediated by STAT1. Science 1996; 272: 719-722.
30. Townsend PA, Scarabelli TM, Davidson SM, et al. STAT-1 interacts with p53 to enhance DNA damage-induced apoptosis. J Biol Chem 2004; 279: 5811-5820.
31. Stephanou A, Brar BK, Knight RA, et al. Opposing actions of STAT-1 and STAT-3 on the Bcl-2 and Bcl-x promoters. Cell Death Differ 2000; 7: 329-330.
32. Nayernia Z, Turchi L, Cosset E, et al. The relationship between brain tumor cell invasion of engineered neural tissues and in vivo features of glioblastoma. Biomaterials 2013; 34: 8279-8290.
33. Francis OE, Bendall M, Manimaran S, et al. Pathoscope: species identification and strain attribution with unassembled sequencing data. Genome Res 2013; 23(10): 1721-1729.
34. Mende DR, Waller AS, Sunagawa S, et al. Assessment of metagenomic assembly using simulated next generation sequencing data. PLoS One 2012; 7: e31386.